Therapeutic advances in leiomyosarcoma
Kristine Peregrino Lacuna(Memorial Sloan Kettering Cancer Center), Gary K. Schwartz(Baylor University Medical Center), Sminu Bose(Memorial Sloan Kettering Cancer Center), Matthew Ingham(Columbia University)
Cited by 49
Related Papers
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
|Nature Genetics|2010|725
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
|Journal of Clinical Oncology|2009|573